Returning for its sixth year, the Practical Radiation Oncology (PRO) Program continues to support the field with a two-day program specifically designed for the community practice radiation oncologist. This program takes place Saturday and Sunday to allow for doctors unable to leave their practice for a week to attend the premier scientific radiation oncology event. Program content is curated to address the needs of a community practice physician and will include disease site reviews, interactive case-based discussions, a coding update and a scientific overview. In addition to being available at a discounted rate as a weekend-only event, the PRO Program will also be included in the full registration package allowing all attendees access.
| Time | Event |
|---|---|
| 7:55 a.m. - 8:00 a.m. | PRO Program Welcome Speaker: Najeeb Mohideen, MD, FASTRO, Northwest Community Hospital |
| 8:00 a.m. - 9:15 a.m. | Session I – Updates in Breast Cancer: Hypofractionation, Treatment Techniques and Systemic Therapy Moderator: Christine Chung, MD, Alta Bates Comprehensive Cancer Center Speakers: Hypofractionation for Breast Cancer Nicolas Prionas, MD, PhD, University of California, San Francisco Breast Radiation Techniques and Motion Management Jolinta Lin, MD, Emory University Advances in Systemic Therapy for Breast Cancer Cathie Chung, MD, Cedars-Sinai Medical Center Q&A |
| 9:30 a.m. - 10:45 a.m. | Session II – The Who, What and How of Sarcoma Moderator: Manpreet Bedi, MD, MS, Medical College of Wisconsin Speakers: Overview of Sarcoma Manpreet Bedi, MD, MS, Medical College of Wisconsin Multidisciplinary Management of Sarcoma Andrew Bishop, MD, The University of Texas MD Anderson Cancer Center Unresectable and Metastatic Disease Anusha Kalbasi, MD, University of California, Los Angeles Radiation Technique and Case Presentation Shauna Rosalie Campbell, DO, Taussig Cancer Institute Q&A |
| 11:00 a.m. - 12:15 p.m. | Session III – Treatment and Management of Larynx Cancer Moderator: Arshin Sheybani, MD, John Stoddard Cancer Center Speakers: Early Stage Larynx Cancer David Sher, MD, MPH, University of Texas Southwestern Medical Center Locally Advanced Larynx Cancer Zain Husain, MD, Southern California Permanente Medical Group Treatment Strategies in Recurrent Larynx Cancer Gary Walker, MD, MS, MPH, Banner MD Anderson Cancer Center Q&A |
| 12:15 p.m. - 1:00 p.m. | Break |
| 1:00 p.m. - 2:15 p.m. | Session IV – Updates in Lung Cancer Management Moderator: Christopher Hayes Pope, MD, CARTI Cancer Center Speakers: Current Management of Stage III Non Small Cell Lung Cancer Saumil Gandhi, MD, PhD, The University of Texas MD Anderson Cancer Center Non Definitive Lung Options: Palliation and XRT Alone Uzoma Ihaegwara, MD, University of Pittsburgh Medical Center Small Cell Lung Cancer Treatment Volumes Sara Zakem, MD, University of Washington Q&A |
| 2:15 p.m. - 3:30 p.m. | Session V – Reirradiation for Prostate, CNS and Head and Neck Cancers Moderator: Sanjeev Aggarwal, MD, Cancer Center at Lake Manassas Speakers: Reirradiation for Local Recurrence of Prostatic Carcinoma Abhishek Solanki, MD, MS, Cardinal Bernardin Cancer Center and Loyola University Reirradiation in Primary and Metastatic CNS Malignancy Susan McGovern, MD, PhD, The University of Texas MD Anderson Cancer Center PRO Retreatment: Head and Neck James Caudell, MD, Moffitt Cancer Center Q&A |
| 3:45 p.m. - 5:00 p.m. | Session VI – Inoperable/Recurrent Endometrial Cancer and Building a Brachytherapy Practice in a Community Setting Moderator: Malolan Rajagopalan, MD, MBA, Radiology, Inc. Speakers: Inoperable Endometrial Cancer J. Thompson, MD, University of Oklahoma Health Sciences Center Recurrent Endometrial Cancer Emma Fields, MD, Virginia Commonwealth University Health System Implementing a Successful Brachytherapy Program in the Community Malolan Rajagopalan, MD, MBA, Mount Carmel Health System Q&A |
| 5:00 p.m. - 6:15 p.m. | Session VII – Management of Primary Brain Tumors in the Molecular Era and Building and Refining a Radiosurgery Program Moderator: Virginia Diavolitsis, MD, Riverside Radiation Oncology Inc. Speakers: Management of Gliomas in the Molecular Era Sara Hardy, MD, University of Rochester Medical Center Management of Large and Multiple Brain Metastases Raju Raval, MD, DPhil, The Ohio State University Wexner Medical Center Starting and Refining a Radiosurgery Program Roshan Prabhu, MD, MS, Southeast Radiation Oncology Group, Levine Cancer Institute Q&A |
| Time | Event |
|---|---|
| 7:55 a.m. - 8:00 a.m. | PRO Program Welcome Speaker: Najeeb Mohideen, MD, FASTRO, Northwest Community Hospital |
| 8:00 a.m. - 9:15 a.m. | Session VIII – Oligometastatic Disease: Practical Aspects of Metastasis-Directed Therapy in a Community Practice Moderator: Beant Gill, MD, Associates in Radiation Medicine Speakers: Data and Dose Selection: To Ablate or Not to Ablate? Beant Gill, MD, Associates in Radiation Medicine Prognostication, Timing and Patient Selection David Palma, MD, PhD, Western University Setting Up for Success Melissa O'Neil, MRT(T), London Health Sciences Centre Q&A |
| 9:30 a.m. - 10:45 a.m. | Session IX – Maximizing Patient Outcomes and Minimizing Morbidity in Gastrointestinal Cancer Moderator: Najeeb Mohideen, MD, FASTRO, Northwest Community Hospital Speakers: Optimizing Multimodality Management of Gastroesophageal Junction Cancer Edward Kim, MD, University of Washington, Fred Hutchinson Cancer Center TNT, W&W and Beyond: Applying the Explosion of Data to Rectal Cancer Practice Krishan Jethwa, MD, Mayo Clinic Advances in Radiation for Pancreatic Cancer Erqi Pollom, MD, MS, Stanford Cancer Institute Q&A |
| 11:00 a.m. - 12:15 p.m. | Session X – Personalization of Systemic Therapy for Localized to Metastatic Prostate Cancer Moderator: Thomas Boike, MD, MMM, GenesisCare USA/Michigan Healthcare Professionals Speakers: Personalizing ADT Use in the Definitive Treatment of Intermediate Risk Prostate Cancer Angela Jia, MD, PhD, Weill Cornell Medical College and New York Presbyterian Hospital Duration and Combination of Systemic Therapies for Patients with High Risk, Node Positive and Oligometastatic Prostate Cancer Brandon Mahal, MD, University of Miami and Sylvester Comprehensive Cancer Center Overview of Systemic Therapies in Metastatic Prostate Cancer Rana McKay, MD, University of California, San Diego Q&A |
